Abstract

Study on synergistic effect of new functionalized Ag nanoparticles for intracellular drug uptake in cancer cells

Highlights

  • It is well known that cancer is one of the major killers to human health, and its morbidity and mortality is in the upward trend in recent years, early diagnosis and effective treatment is very important

  • Our results show that the nanocomposites can effectively enhance the accumulation of anticancer drugs into the cancer cells, thereby greatly increasing the intracellular drug concentration in leukemia cells and enhancing the lethal effect on cancer cells

  • Daunorubicin was purchased from Nanjing pharmacy factory, and stock solutions were freshly prepared by sterilized phosphate buffer solution (PBS) (0.1 molL-1, pH=7.2) and stored in the dark at 4°C

Read more

Summary

. Introduction

It is well known that cancer is one of the major killers to human health, and its morbidity and mortality is in the upward trend in recent years, early diagnosis and effective treatment is very important. With the feature of excellent bio-compatibility, Ag NPs play an important role in biomedical applications [15,16,17,18,19]. In this contribution, we have explored the combination of the functionalized Ag nanoparticles with anticancer drugs daunorubicin (DNR) to form a new biocompatible nanocomposite to facilitate the cellular drug uptake in leukemia cells. Our results show that the nanocomposites can effectively enhance the accumulation of anticancer drugs into the cancer cells, thereby greatly increasing the intracellular drug concentration in leukemia cells and enhancing the lethal effect on cancer cells

Reagents
In vitro cytotoxicity study of functionalized Ag NPs
Fluorescence microscopy
The proliferation inhibition of DNR-Ag NPs complexes on K562 cells
Electrochemical Analysis
UV-Vis absorption spectroscopic assay
Cytoxicity assay of Ag NPs on leukemia K562 cancer cells
TIRFM of Ag NPs on K562 cancer cells
Electrochemical assay
UV-Vis absorption spectroscopy study
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.